Skip to content

ScienceProfluent Bio

Profluent

Generative protein language models that design novel proteins.

Category
Science
Pricing
PAID
Hosting
Cloud
Platforms
Web
Verified
Jun 14, 2026

Profluent uses generative AI — its ProGen-lineage protein language models — to author novel proteins from scratch or from natural scaffolds, for medicine and agriculture. It released OpenCRISPR-1, described as the first AI-designed gene editor (open-licensed and published in Nature), and is expanding into antibodies and enzymes. It operates as an AI protein-design company working through partnerships with open-sequence releases, not a self-serve consumer platform.

Pros & cons

  • ProGen protein-LLM lineage
  • Open-released gene editor
  • Nature-published work
  • Eli Lilly and IDT partnerships
  • Partnership/licensing only
  • No self-serve platform
  • Open releases are sequences, not a service
  • Opaque pricing

Tags

Further reading

View all Science
  • View Cradle details
    SciencePAID

    Cradle

    Cradle

    AI protein-engineering platform for faster lab design rounds.

    Cradle is an AI-powered protein-engineering SaaS platform that guides scientists through design rounds — candidate generation, multi-property optimization, and results analysis — using ML models trained per-customer on proprietary wet-lab data. It runs its own validation wet lab in Amsterdam and serves biopharma and industrial-biotech R&D teams including Novo Nordisk and Johnson & Johnson. It is sold via subscription with no royalties, and customers keep full IP.

    Worth knowing

    Amsterdam-based; raised a $73M Series B led by IVP in Nov 2024, taking total funding past $100M, and runs its own validation wet lab.

    • protein-engineering
    • biotech
    • drug-discovery
  • View EvolutionaryScale details
    ScienceFREEMIUMOpen core

    EvolutionaryScale

    EvolutionaryScale

    Frontier protein language models (the ESM family) for biology.

    EvolutionaryScale builds frontier protein language models — the ESM family, including ESM3, which reasons jointly over sequence, structure, and function. ESM3-open ships open weights and code under a non-commercial license, while larger models are served via its Forge API and AWS/NVIDIA partnerships. It is both an open-model provider and an API platform for protein design and understanding.

    Worth knowing

    Founded in 2023 by ex-Meta FAIR scientists after Meta cut its protein team; launched ESM3 with a $142M seed round.

    • protein-language-model
    • esm3
    • biotech
    • open-weights
  • View Chai Discovery details
    ScienceFREEMIUMOpen core

    Chai Discovery

    Chai Discovery

    Foundation models for molecular structure and antibody design.

    Chai Discovery builds foundation models for drug discovery — Chai-1 for biomolecular structure prediction across proteins, ligands, DNA/RNA, and glycans, and Chai-2 for de novo antibody design. Chai-1 weights and inference code are released for non-commercial use, and a free web server runs the model in-browser. It is both a model provider and a usable platform.

    Worth knowing

    OpenAI-backed; raised a $130M Series B at a ~$1.3B valuation in Dec 2025, co-led by Oak HC/FT and General Catalyst.

    • protein-structure
    • antibody-design
    • drug-discovery
    • open-weights